Boston Scientific Neuromodulation

  • Société-mère du fabricant (2017)
  • Commentaire du fabricant
    “We take a patient-first approach to assessing the applicability of every recall and communicate to regulatory bodies in all geographies where the recalled device is sold,” Boston Scientific said in a statement to ICIJ. “We have coordinated several recalls across many countries in a timely manner,” the company said, adding that it complies with all national laws, which can often vary and require different processes for reporting information or taking action on recalls. The company said it uses a rigorous and uniform process to take action on recalls and that “when we initiate a field action (e.g. recall, safety alert), every customer who has received an affected product receives a communication that includes a letter for the physician.”
  • Source
    SATP
  • 1 Event

Un dispositif médical dans la base de données

  • Modèle / numéro de série
    UPN M365SC53000 (SC-5300) | to be listed on the verification form | manufactured during the period of Dec 03 to June 07
  • Description du dispositif
    MD: Battery charger

2 fabricants avec un nom similaire

En savoir plus sur les données ici

  • Adresse du fabricant
    VALENCIA
  • Source
    HC
  • Adresse du fabricant
    Boston Scientific Neuromodulation Corporation, 25155 Rye Canyon Loop, Valencia CA 91355-5004
  • Société-mère du fabricant (2017)
  • Commentaire du fabricant
    “We take a patient-first approach to assessing the applicability of every recall and communicate to regulatory bodies in all geographies where the recalled device is sold,” Boston Scientific said in a statement to ICIJ. “We have coordinated several recalls across many countries in a timely manner,” the company said, adding that it complies with all national laws, which can often vary and require different processes for reporting information or taking action on recalls. The company said it uses a rigorous and uniform process to take action on recalls and that “when we initiate a field action (e.g. recall, safety alert), every customer who has received an affected product receives a communication that includes a letter for the physician.”
  • Source
    USFDA